Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. News
    3. Search results
    Displaying results 6801 - 6825 of 43581 Clear search
    Cambridge Innovation Capital
    14 Jan 2022

    Cambridge Innovation Capital looks back on 'transformational year'

    Cambridge Innovation Capital presents a video which summarises some of its achievements in 2021, which was a "transformational year" for CIC, according to  Managing Partner Andrew Williamson.

    Cambridge University Health Partners (CUHP)
    14 Jan 2022

    New coordinator appointed to lead regional Alzheimer's research network

    Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) honorary consultant old age psychiatrist Dr Ben Underwood has been appointed as the new coordinator for the Alzheimer’s Research UK (ARUK) East Network.

    IDTechEx
    14 Jan 2022

    The market momentum in RFID, discussed by IDTechEx

    Almost two years after the COVID-19 outbreak began, the world is still in the tunnel. Despite the negative impact the pandemic has caused, there are some positive sides. For example, it accelerates digitalisation - businesses are pushed to adopt technologies quicker to improve production as well as management efficiency.

    University of Cambridge (cam.ac.uk)
    14 Jan 2022

    Early-career researchers win major European grants

    Nine Cambridge researchers have risen to the top of over 4,000 proposals to secure prestigious European Research Council (ERC) Starting Grants, the most achieved by any UK institution.

    Ieso Digital Health
    14 Jan 2022

    ieso shortlisted for HSJ Partnership Awards 2022

    ieso is delighted to announce that their joint submission in partnership with Dorset HealthCare University NHS Foundation Trust has been shortlisted for Best Mental Health Partnership With the NHS at the HSJ Partnership Awards 2022, recognising their outstanding contribution to healthcare – in what has been an exceptional and challenging period across the sector.

    ThoughtRiver
    14 Jan 2022

    ThoughtRiver offers free trial of Purely NDA – a new out-of-the-box NDA review tool

    Legal technology company ThoughtRiver is now offering a free trial of its newly released out-of-the-box NDA review tool: Purely NDA. Developed in partnership with World Commerce & Contracting (Woldcc), the tool uses ThoughtRiver’s proprietary AI to review third party NDAs against a risk policy that directly aligns with WorldCC’s contracting principles.

    Zyme Communications
    13 Jan 2022

    Insightful Science acquires Omiq to add cloud-based machine learning to its flow cytometry capabilities

    OMIQ is a powerful flow cytometry SaaS solution adopted by leading global biopharma labs.

    Cambridge Norwich Tech Corridor
    13 Jan 2022

    New strategic partnership aims to accelerate microbiome analysis through AI-augmented knowledge discovery platform

    Today, Eagle Genomics, the Deep Tech software business pioneering the application of network science to biology, and the Quadram Institute, a world-leading institute creating new interfaces between food science, gut biology, and human health, are pleased to announce a new partnership committed to promoting the understanding of microbiome science.

    Zyme Communications
    13 Jan 2022

    The Native Antigen Company expands range of Norovirus-like particles

    Oxford, UK: The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, has announced the expansion of its norovirus-like particle range, with the addition of six new reagents, including four which are unique to the market. These virus-like…

    University of Cambridge (cam.ac.uk)
    13 Jan 2022

    Learning through ‘guided’ play can be as effective as adult-led instruction

    Play-based learning may also have a more positive effect on younger children’s acquisition of important early maths skills compared with traditional, direct instruction.

    Cambridge University Hospitals NHS Foundation Trust
    13 Jan 2022

    Trust backs trial into treatment for severe hearing loss

    Addenbrooke’s Hospital is to support a national study into the best treatment options for adults living with severe hearing loss.

    Cambridgeshire & Peterborough Combined Authority
    13 Jan 2022

    St Ives travel preferences revealed as transport panel approves next steps for unified A141 improvement scheme

    At its first meeting of 2022, the Transport and Infrastructure Committee of the Cambridgeshire & Peterborough Combined Authority heard how bypass and active travel options for St Ives got the thumbs-up from the public.

    Abcam plc
    13 Jan 2022

    Abcam in Glassdoor’s top 5 ‘best places to work in the UK’ for second consecutive year

    Abcam, a global innovator empowering life science researchers with high-quality biological reagents and tools critical to research, drug discovery and diagnostics, has received the Employees’ Choice Award 2022, recognising Abcam in Glassdoor’s Best Places to Work in the UK. Abcam is the first biotech company to be ranked in the top five for two years in a row1.

    Luminance
    13 Jan 2022

    French law firm Lerins & BCW deploys Luminance’s AI for contract review and knowledge management

    London, UK, and Paris, France - Leading French business law firm, Lerins & BCW, has announced its adoption of Luminance’s next-generation artificial intelligence to enhance its contract review and knowledge management capabilities.

    Domino Printing Sciences plc
    13 Jan 2022

    Domino collaborates with Cambridge University on ground-breaking inks research

    A Cambridge company is partnering with academia to solve a long-standing issue in its sector which will deliver benefits to customers and enable further improvements for the coding and marking industry as a whole.

    Team Consulting Ltd
    12 Jan 2022

    Respiratory devices: trends to watch in 2022

    Attending the Drug Delivery to the Lungs (DDL) conference is always an exciting time, says Team Consulting.

    Excellence First Enterprise Consultancy
    12 Jan 2022

    What the EU is trying to change in the years ahead

    The North Sea Region Programme of the European Union announced its first call for Projects under the new 2021-2027 programme on 16 December, 2021. EFEC is working with University of Groningen to develop a project proposal to speed up technology transfer in the circular economies of rural areas. 

    PhoreMost
    12 Jan 2022

    NeoCura and PhoreMost announce research collaboration to explore novel cancer therapeutics

    NeoCura Bio-Medical Technology Co Ltd, a leading RNA-based drug research and development company in China, and PhoreMost Limited, the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’, have announced an oncology drug discovery research collaboration.

    Cambridge City Council
    12 Jan 2022

    Groups invited to apply for Area Committee and Platinum Jubilee grants

    Groups delivering projects that benefit local communities could be eligible for grants from Cambridge City Council.

    Cambridge Judge Business School, University of Cambridge
    12 Jan 2022

    Board reform is subject of new book

    Improving board effectiveness requires a focus on the relationship aspect of boards as well as their structure, says a new book by Dr Philip Stiles of Cambridge Judge.

    IDTechEx
    12 Jan 2022

    IDTechEx discusses the potential of printed piezoelectric sensors

    Printed pressure sensors are a well-established technology, having been used for applications such as car occupancy sensors, electric pianos, and some medical devices. To date, such sensors have always been based on piezoresistive materials, in which applying pressure increases conductivity. In contrast, despite extensive R&D printed piezoelectric sensors, in which applying pressure produces…

    Zyme Communications
    11 Jan 2022

    NeoCura and PhoreMost announce research collaboration to explore novel cancer therapeutics

    Shenzhen, China and Cambridge, UK: NeoCura Bio-Medical Technology Co., Ltd. (“NeoCura”), a leading RNA-based drug research and development company in China, and PhoreMost Limited (PhoreMost), the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’, have announced an oncology drug discovery research collaboration.

    Breathe Technology Ltd
    11 Jan 2022

    Breathe Technology supports your IT needs

    Breathe Technology wants to reach out to offer assistance as one of the region’s leading IT & Comms providers.

    Crescendo Biologics Limited
    11 Jan 2022

    BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision immunotherapies

    BioNTech SE (Nasdaq: BNTX) and Crescendo Biologics Ltd, a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, announced that they have entered a multi-target discovery collaboration to develop novel immunotherapies for the treatment of patients with cancer and other diseases. The initial term of the discovery collaboration is three years.

    Illumina
    11 Jan 2022

    Illumina delivers 2021 results ahead of expectations

    Multiple innovative partnerships with healthcare companies, research institutions, and multiomic developers, along with new groundbreaking technologies, including a new SBS chemistry and long-read capabilities, position Illumina to accelerate genomic adoption and improve human health globally.

    Pagination

    • First page «
    • Previous page ‹
    • …
    • Page 271
    • Page 272
    • Current page 273
    • Page 274
    • Page 275
    • …
    • Next page ›
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS